Overview

  • Product nameAnti-CXCL2 antibody
    See all CXCL2 primary antibodies
  • Description
    Goat polyclonal to CXCL2
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Cynomolgus Monkey
  • Immunogen

    Synthetic peptide corresponding to Human CXCL2 aa 94-107 (C terminal). Synthetic peptide:

    C-KKIIEKMLKNGKSN

    , corresponding to C terminal amino acids 94-107 of Human GRO beta (NP_002080.1).
    Sequence:

    C-KKIIEKMLKNGKSN

  • Positive control
    • Human duodenum lysate

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris saline, pH 7.3
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesab91511 was purified from goat serum by ammonium sulphate precipitation, followed by antigen affinity chromatography using the immunizing peptide.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab91511 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.03 - 0.1 µg/ml. Detects a band of approximately 17 kDa (predicted molecular weight: 11 kDa).

Target

  • FunctionProduced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity.
  • Sequence similaritiesBelongs to the intercrine alpha (chemokine CxC) family.
  • Post-translational
    modifications
    The N-terminal processed form GRO-beta(5-73) is produced by proteolytic cleavage after secretion from bone marrow stromal cells.
  • Cellular localizationSecreted.
  • Information by UniProt
  • Database links
  • Alternative names
    • C-X-C motif chemokine 2 antibody
    • Chemokine (C X C motif) ligand 2 antibody
    • Chemokine, CXC motif, ligand 2 antibody
    • CINC 2a antibody
    • CINC2a antibody
    • CINC3 antibody
    • CXC chemokine antibody
    • CXCL 2 antibody
    • Cxcl2 antibody
    • CXCL2_HUMAN antibody
    • Cytokine-induced neutrophil chemoattractant 3 antibody
    • GRO 2 antibody
    • GRO b antibody
    • GRO protein, beta antibody
    • Gro-beta antibody
    • GRO-beta(5-73) antibody
    • GRO-beta-T antibody
    • GRO2 antibody
    • GRO2 oncogene antibody
    • GROb antibody
    • GRObeta antibody
    • Growth regulated protein beta antibody
    • Growth-regulated protein beta antibody
    • GROX antibody
    • Hematopoietic synergistic factor antibody
    • HSF antibody
    • Macrophage inflammatory protein 2 alpha antibody
    • Macrophage inflammatory protein 2 antibody
    • Macrophage inflammatory protein 2-alpha antibody
    • Melanoma growth stimulatory activity beta antibody
    • MGSA b antibody
    • MGSA beta antibody
    • MIP 2 antibody
    • MIP 2a antibody
    • MIP2 alpha antibody
    • MIP2 antibody
    • MIP2-alpha antibody
    • MIP2A antibody
    • MIP2alpha antibody
    • SB-251353 antibody
    • SCYB 2 antibody
    • Scyb antibody
    • SCYB2 antibody
    • Small inducible cytokine subfamily B, member 2 antibody
    see all

Anti-CXCL2 antibody images

  • Anti-CXCL2 antibody (ab91511) at 0.2 µg/ml + Human duodenum lysate at 35 µg
    Developed using the ECL technique

    Predicted band size : 11 kDa
    Observed band size : 17 kDa (why is the actual band size different from the predicted?)


    Exposure time : 1 hour


  • Predicted band size : 11 kDa
    ab91511 (0.03µg/ml) staining of Daudi lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence

References for Anti-CXCL2 antibody (ab91511)

This product has been referenced in:
  • Magni S  et al. miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease. Am J Gastroenterol N/A:N/A (2014). Read more (PubMed: 25070052) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab91511.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"